LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants

Epigenetics

Volumn 9, Issue 3, 2013, Pages 404-415

  Andreotti, Gabriella ^a   Karami, Sara ^a   Pfeiffer, Ruth M ^a   Hurwitz, Lauren ^a   Liao, Linda M ^a   Weinstein, Stephanie J ^a   Albanes, Demetrius ^a   Virtamo, Jarmo ^b   Silverman, Debra T ^a   Rothman, Nathaniel ^a   Moore, Lee E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

ATBC; Bladder cancer; Global methylation; Nested case control; PLCO; Pre diagnostic blood DNA

Indexed keywords

5 METHYLCYTOSINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; FEEDING BEHAVIOR; FEMALE; GENETIC ANALYSIS; HUMAN; LONG INTERSPERSED NUCLEAR ELEMENT 1 METHYLATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING;

ATBC; BLADDER CANCER; GLOBAL METHYLATION; NESTED CASE-CONTROL; PLCO; PRE-DIAGNOSTIC BLOOD DNA;

AGED; COHORT STUDIES; DNA; DNA METHYLATION; EUROPE; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SMOKING; UNITED STATES; URINARY BLADDER NEOPLASMS;

EID: 84899154017     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.27386     Document Type: Article

References (29)

1. Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol 2009; 27:289-93; PMID:19219610; http://dx.doi.org/10.1007/s00345-009-0383-3
2. Silverman DT, Devesa SS, Moore LE, Rothman N. Bladder cancer. In: Schottenfeld D, Fraumeni Jr. JF, editors. Cancer epidemiology and prevention. 3rd ed. Oxford; Oxford University Press;2006.
3. Amling CL. Diagnosis and management of superficial bladder cancer. Curr Probl Cancer 2001; 25:219-78; PMID:11514784; http://dx.doi.org/10.1067/ mcn.2001.117539
4. Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, Silverman D, García-Closas R, Chanock S, Tardón A, Serra C, et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol 2008; 9:359-66; PMID:18339581; http://dx.doi.org/10.1016/ S1470-2045(08)70038-X
5. Wilhelm CS, Kelsey KT, Butler R, Plaza S, Gagne L, Zens MS, Andrew AS, Morris S, Nelson HH, Schned AR, et al. Implications of LINE1 methylation for bladder cancer risk in women. Clin Cancer Res 2010; 16:1682-9; PMID:20179218; http://dx.doi. org/10.1158/1078-0432.CCR-09-2983
6. Cash HL, Tao L, Yuan JM, Marsit CJ, Houseman EA, Xiang YB, Gao YT, Nelson HH, Kelsey KT. LINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese. Int J Cancer 2012; 130:1151-9; PMID:21445976; http://dx.doi. org/10.1002/ijc.26098
7. Patchsung M, Boonla C, Amnattrakul P, Dissayabutra T, Mutirangura A, Tosukhowong P. Long interspersed nuclear element-1 hypomethylation and oxidative stress: correlation and bladder cancer diagnostic potential. PLoS One 2012; 7:e37009; PMID:22615872; http://dx.doi.org/10.1371/journal. pone.0037009
8. Yang AS, Estécio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004; 32:e38; PMID:14973332; http://dx.doi.org/10.1093/nar/ gnh032
9. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, Ehrlich M, Laird PW. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005; 33:6823-36; PMID:16326863; http://dx.doi.org/10.1093/nar/ gki987
10. Nelson HH, Marsit CJ, Kelsey KT. Global methylation in exposure biology and translational medical science. Environ Health Perspect 2011; 119:1528-33; PMID:21669556; http://dx.doi. org/10.1289/ehp.1103423
11. Schulz WA. Do DNA-methylation changes also occur in blood? Lancet Oncol 2008; 9:312-3; PMID:18374285; http://dx.doi.org/10.1016/ S1470-2045(08)70083-4
12. Brennan K, Flanagan JM. Is there a link between genome-wide hypomethylation in blood and cancer risk? Cancer Prev Res (Phila) 2012; 5:1345-57; PMID:23135621; http://dx.doi.org/10.1158/1940-6207.CAPR-12-0316
13. Woo HD, Kim J. Global DNA hypomethylation in peripheral blood leukocytes as a biomarker for cancer risk: a meta-analysis. PLoS One 2012; 7:e34615; PMID:22509334; http://dx.doi.org/10.1371/ journal.pone.0034615
14. Dukes JW, Tierney LM Jr. Paraneoplastic leukemoid reaction as marker for transitional cell carcinoma recurrence. Urology 2009; 73:e17-9; PMID:18718647; http://dx.doi.org/10.1016/j. urology.2008.05.023
15. Wu HC, Delgado-Cruzata L, Flom JD, Kappil M, Ferris JS, Liao Y, Santella RM, Terry MB. Global methylation profiles in DNA from different blood cell types. Epigenetics 2011; 6:76-85; PMID:20890131; http://dx.doi.org/10.4161/epi.6.1.13391
16. Reinius LE, Acevedo N, Joerink M, Pershagen G, Dahlén SE, Greco D, Söderhäll C, Scheynius A, Kere J. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 2012; 7:e41361; PMID:22848472; http://dx.doi.org/10.1371/ journal.pone.0041361
17. Adalsteinsson BT, Gudnason H, Aspelund T, Harris TB, Launer LJ, Eiriksdottir G, Smith AV, Gudnason V. Heterogeneity in white blood cells has potential to confound DNA methylation measurements. PLoS One 2012; 7:e46705; PMID:23071618; http:// dx.doi.org/10.1371/journal.pone.0046705
18. Xu X, Gammon MD, Hernandez-Vargas H, Herceg Z, Wetmur JG, Teitelbaum SL, Bradshaw PT, Neugut AI, Santella RM, Chen J. DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study. FASEB J 2012; 26:2657-66; PMID:22371529; http://dx.doi.org/10.1096/fj.11-197251
19. Liao LM, Brennan P, van Bemmel DM, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, et al. LINE-1 methylation levels in leukocyte DNA and risk of renal cell cancer. PLoS One 2011; 6:e27361; PMID:22076155; http://dx.doi.org/10.1371/journal. pone.0027361
20. Sánchez-Carbayo M. Hypermethylation in bladder cancer: biological pathways and translational applications. Tumour Biol 2012; 33:347-61; PMID:22274923; http://dx.doi.org/10.1007/ s13277-011-0310-2
21. Brennan K, Garcia-Closas M, Orr N, Fletcher O, Jones M, Ashworth A, Swerdlow A, Thorne H, Riboli E, Vineis P, et al.; KConFab Investigators. Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk. Cancer Res 2012; 72:2304-13; PMID:22374981; http://dx.doi. org/10.1158/0008-5472.CAN-11-3157
22. Gohagan JK, Prorok PC, Hayes RB, Kramer BS; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials 2000; 21(Suppl):251S-72S; PMID:11189683; http:// dx.doi.org/10.1016/S0197-2456(00)00097-0
23. Hayes RB, Sigurdson A, Moore L, Peters U, Huang WY, Pinsky P, Reding D, Gelmann EP, Rothman N, Pfeiffer RM, et al.; PLCO Trial Team. Methods for etiologic and early marker investigations in the PLCO trial. Mutat Res 2005; 592:147-54; PMID:16054167; http://dx.doi.org/10.1016/j.mrfmmm.2005.06.013
24. Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Palmgren J, Freedman LS, Haapakoski J, et al. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, betacarotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996; 88:1560-70; PMID:8901854; http:// dx.doi.org/10.1093/jnci/88.21.1560
25. Nelson HH, Marsit CJ, Kelsey KT. Global methylation in exposure biology and translational medical science. Environ Health Perspect 2011; 119:1528-33; PMID:21669556; http://dx.doi. org/10.1289/ehp.1103423
26. Brennan K, Flanagan JM. Is there a link between genome-wide hypomethylation in blood and cancer risk? Cancer Prev Res (Phila) 2012; 5:1345-57; PMID:23135621; http://dx.doi.org/10.1158/1940-6207.CAPR-12-0316
27. Royo JL, Hidalgo M, Ruiz A. Pyrosequencing protocol using a universal biotinylated primer for mutation detection and SNP genotyping. Nat Protoc 2007; 2:1734-9; PMID:17641638; http://dx.doi. org/10.1038/nprot.2007.244
28. Brakensiek K, Wingen LU, Länger F, Kreipe H, Lehmann U. Quantitative high-resolution CpG island mapping with Pyrosequencing reveals diseasespecific methylation patterns of the CDKN2B gene in myelodysplastic syndrome and myeloid leukemia. Clin Chem 2007; 53:17-23; PMID:17095538; http:// dx.doi.org/10.1373/clinchem.2007.072629
29. England R, Pettersson M. Pyro Q-CpG™: Quantitative analysis of methylation in multiple CpG sites by pyrosequencing. Nat Methods 2005; 2:1-2; http://dx.doi.org/10.1038/nmeth800